Tags: Drug.

Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories and commercialised in Spain since 1981. Currently it is available in 25 countries in Europe Asia Africa and America. It is a drug of the salicylate family but it is not a derivative of acetylsalicylic acid (ASA). Trade names include Disgren Grendis Aflen and Triflux

Triflusal.png
ATC prefix
B01
ATC suffix
AC18
FDA UNII code
1Z0YFI05OO
IUPAC name
2-acetyloxy-4-(trifluoromethyl)benzoic acid
PubChem
9458

Loading...

This page contains content from the copyrighted Wikipedia article "Triflusal"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.